BNN — BRAIN Biotech AG Cashflow Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeMicro CapNeutral

Annual cashflow statement for BRAIN Biotech AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4.68	-6.34	-8.11	-11.1	-11.8
Depreciation
Deferred Taxes
Non-Cash Items	-4.82	-3.07	-1.35	-2.76	2.4
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1.34	3.64	0.139	5.44	-4.54
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-3.91	-1.49	-4.22	-3.58	-9.23
Capital Expenditures	-1.26	-6.08	-2.64	-1.73	-1.61
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.918	-6.6	3.2	0.04	0.05
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2.18	-12.7	0.562	-1.69	-1.56
Financing Cash Flow Items	14.4	0	-9.59	0.6	-1.7
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	11.6	-1.97	0.459	27	-10.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	5.6	-16.1	-3.09	21.8	-21